The neuropathies of Waldenström's Macroglobulinemia (WM) and IgM-MGUS

Canadian Journal of Neurological Sciences

Volumn 38, Issue 2, 2011, Pages 289-295

  Klein, Christopher J ^a   Moon, Joon Shik ^a   Mauermann, Michelle L ^a   Zeldenrust, Steven R ^a   Wu, Yanhong ^a   Dispenzieri, Angela ^a   Dyck, Peter J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M;

ADULT; AGED; ANEMIA; ARTICLE; BONE MARROW BIOPSY; DEMYELINATION; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MUSCLE ACTION POTENTIAL; NERVE BIOPSY; NERVE CONDUCTION; NEUROPATHY; PRIORITY JOURNAL; WALDENSTROEM MACROGLOBULINEMIA;

EID: 79951745066     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100011483     Document Type: Article

References (35)

1. Kyle RA. Neuropathy associated with the monoclonal gammopathies. In: Noseworthy JH, editor. Neurologic therapeautics: principles and practice. London, New York: Martin Dunitz; 2003. p. 2126-36.
2. Lozeron P, Adams D. Monoclonal gammopathy and neuropathy. Curr Opin Neurol. 2007 Oct;20(5):536-41. (Pubitemid 47462282)
3. Katz JS, Saperstein DS, Gronseth G, Amato AA, Barohn RJ. Distal acquired demyelinating symmetric neuropathy. Neurology. 2000;54:615-20. (Pubitemid 30082927)
4. Levine T, Pestronk A, Florence J, et al. Peripheral neuropathies in Waldenstrom's macroglobulinaemia. J Neurol Neurosurg Psychiatry. 2006 Feb;77(2):224-8.
5. Baldini L, Nobile-Orazio E, Guffanti A, et al. Peripheral neuropathy in IgM monoclonal gammopathy andWaldenstrom's macroglobulinemia: a frequent complication in elderly males with low MAG-reacitve serum monoclonal component. Am J Hematol. 1994;45:25-31. (Pubitemid 23362871)
6. Owen RG, Treon SP, Al-Katib A, et al. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Semin Oncol. 2003 Apr;30(2):110-5. (Pubitemid 36506291)
7. Gertz MA. Waldenstrom macroglobulinemia: a review of therapy. Am J Hematol. 2005 Jun;79(2):147-57.
8. Kaku DA, England JD, Sumner AJ. Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated glycoprotein and sulphated glucuronyl paragloboside. Brain. 1994 Oct;117(Pt 5):941-7. (Pubitemid 24350530)
9. Lupu VD, Mora CA, Dambrosia J, Meer J, Dalakas M, Floeter MK. Terminal latency index in neuropathy with antibodies against myelin-associated glycoproteins. Muscle Nerve. 2007 Feb;35 (2):196-202.
10. Capasso M, Torrieri F, Di Muzio A, De Angelis MV, Lugaresi A, Uncini A. Can electrophysiology differentiate polyneuropathy with anti-MAG/SGPG antibodies from chronic inflammatory demyelinating polyneuropathy? Clin Neurophysiol. 2002 Mar; 113(3):346-53. (Pubitemid 34233856)
11. Attarian S, Azulay JP, Boucraut J, Escande N, Pouget J. Terminal latency index and modified F ratio in distinction of chronic demyelinating neuropathies. Clin Neurophysiol. 2001 Mar;112 (3):457-63. (Pubitemid 32166926)
12. Bain PG, Britton TC, Jenkins IH, et al. Tremor associated with benign IgM paraproteinaemic neuropathy. Brain. 1996 Jun;119 (Pt 3):789-99. (Pubitemid 26237177)
13. Gabriel JM, Erne B, Miescher GC, et al. Selective loss of myelinassociated glycoprotein from myelin correlates with anti-MAG antibody titre in demyelinating paraproteinaemic polyneuropathy. Brain. 1996;119:775-87. (Pubitemid 26237176)
14. Hays AP, Latov N, Takatsu M, Sherman WH. Experimental demyelination of nerve induced by serum of patients with neuropathy and an anti-MAG IgM M-protein. Neurology. 1987 Feb;37(2):242-56 (Pubitemid 17015497)
15. Tatum AH. Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti-myelin-associated glycoprotein. Ann Neurol. 1993 May;33(5):502-6. (Pubitemid 23143034)
16. Gosselin S, Kyle RA, Dyck PJ. Neuropathy associated with monoclonal gammopathies of undetermined significance. Ann Neurol. 1991;30:54-61.
17. Suarez GA, Kelley JJ. Polyneuropathy associated with monoclonal gammopathy of undetermined significance: Further evidence that IgM-MGUS neuropathies are different than IgG-MGUS. Neurology. 1993;43:1304-8. (Pubitemid 23213798)
18. Garces-Sanchez M, Dyck PJ, Kyle RA, et al. Antibodies to myelinassociated glycoprotein (anti-Mag) in IgM amyloidosis may influence expression of neuropathy in rare patients. Muscle Nerve. 2008 Apr;37(4):490-5. (Pubitemid 351501976)
19. Kraft GH, Halvorson GA. Median nerve residual latency: normal value and use in diagnosis of carpal tunnel syndrome. Arch Phys Med Rehabil. 1983 May;64(5):221-6. (Pubitemid 13092368)
20. Radziwill AJ, Steck AJ, Renaud S, Fuhr P. Distal motor latency and residual latency as sensitive markers of anti-MAG polyneuropathy. J Neurol. 2003 Aug;250(8):962-6. (Pubitemid 37041028)
21. Shahani B, Young R, Potts F, Maccabee P. Terminal latency index (TLI) and late response studies in motor neuron disease (MND), peripheral neuropathies and entrapment syndromes (abstract). Acta Neurol Scand. 1979; Suppl 73:118.
22. Mauermann ML, Burns TM. Pearls and Oysters: evaluation of peripheral neuropathies. Neurology. 2009 Feb 10;72(6):e28-31.
23. Dyck PJ, Dyck PJB, Chalk CH. The 10 P's: a mnemonic helpful in characterization and differential diagnosis of peripheral neuropathy. Neurology. 1992;42:14-8.
24. Low PA, Benarroch EE. Clinical autonomic disorders: Philadelphia. Wolters Kluwer; 2008.
25. Low PA. Composite autonomic scoring scale for laboratory quantification of generalized autonomic failure. Mayo Clin Proc. 1993 Aug;68(8):748-52. (Pubitemid 23222298)
26. Dyck PJ, Sherman WR, Hallcher LM, et al. Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol. 1980;8(6):590-6. (Pubitemid 11213503)
27. Daube J. Clinical Neurophysiology. 1st ed. Philadelphia: Davis; 1996.
28. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Neurology. 1991 May;41(5):617-8.
29. Dyck PJ, O'Brien PC, Litchy WJ, Harper CM, Daube JR, Dyck PJB. Use of percentiles and normal deviates to express nerve conduction and other test abnormalities. Muscle Nerve. 2001; 24:307-10. (Pubitemid 32172705)
30. Dyck PJ, Litchy WJ, Lehman KA, Hokanson JL, Low PA, O'Brien PC. Variables influencing neuropathic endpoints: the Rochester Diabetic Neuropathy Study of Healthy Subjects. Neurology. 1995 Jun;45(6):1115-21.
31. O'Brien PC, Dyck PJ. Procedures for setting normal values. Neurology. 1995 Jan;45(1):17-23.
32. Daube JR. Clinical neurophysiology (CD disc monogram of EMG needle examination). New York: Oxford University Press; 2009.
33. Dyck PJ, Dyck PJB, Giannini C, Sahenk Z, AJ W, Engelstad J. Peripheral nerves. In: Graham DI, Lantos PL, editors. Greenfields Neuropathology. London: Oxford University Press; 2002. p. 551-675.
34. McMaster ML, Kristinsson SY, Turesson I, Bjorkholm M, Landgren O. Novel aspects pertaining to the relationship of Waldenstrom's macroglobulinemia, IgM monoclonal gammopathy of undetermined significance, polyclonal gammopathy, and hypoglobulinemia. Clin Lymphoma Myeloma. 2009 Mar;9 (1):19-22.
35. Facon T, Brouillard M, Duhamel A, et al. Prognostic factors in Waldenstrom's macroglobulinemia: a report of 167 cases. J Clin Oncol. 1993 Aug;11(8):1553-8. (Pubitemid 23228262)